Grifols, S.A. (GRFS) Social Stream



Grifols, S.A. (GRFS): $7.67

0.01 (-0.13%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add GRFS to Watchlist
Sign Up

GRIFOLS SA (GRFS) Price Targets From Analysts

Use the tables below to see what analysts covering GRIFOLS SA think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-05 3 $17.7 $17.7 $17.7 $7.96 122.36%
2021-11-14 4 $19.2 $17.7 $18.45 $7.96 131.78%
2022-01-04 3 $12.5 $12.5 $12.5 $7.96 57.04%
2022-03-04 4 $13 $13 $13 $7.96 63.32%
2022-09-14 3 $10.4 $10.4 $10.4 $7.96 30.65%
2022-12-05 2 $9.15 $9.15 $9.15 $7.96 14.95%
2023-01-03 2 $9 $9 $9 $7.96 13.07%
2023-07-17 2 $9 $9 $9 $7.96 13.07%
2023-09-05 3 $10 $10 $10 $7.96 25.63%
2023-11-14 3 $15 $10 $12.5 $7.96 57.04%
2023-12-06 3 $15 $10.5 $12.75 $7.96 60.18%

The Trend in the Analyst Price Target


GRFS's average price target has moved down $16.08 over the prior 44 months.

Over the past 38 weeks, GRFS's average upside potential has been 23.6%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-09-05 3 10 10.0 10.00 9.31 7.41%
2023-09-12 3 15 10.0 12.50 9.70 28.87%
2023-09-14 3 15 10.0 12.50 9.86 26.77%
2023-10-14 3 15 10.0 12.50 8.80 42.05%
2023-12-06 3 15 10.5 12.75 10.00 27.5%

GRFS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


GRFS's average broker recommendation rating improved by 1.33 over the prior 21 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GRFS as an investment opportunity.

  • GRIFOLS SA's number of analysts covering the stock is higher than 15.16% of stocks in the large market cap category.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, GRIFOLS SA's variance in analysts' estimates is lower than 50.79% of them.
  • GRIFOLS SA's average analyst price target is higher than 73.65% of stocks in the large market cap category.
  • GRFS has a higher upside potential (average analyst target price relative to current price) than 980.14% of stocks in the large market cap category.

Stocks similar to GRIFOLS SA in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SNY, GLPG, and VTRS.

Is GRFS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!